SV Health Investors

SV Health Investors has a direct presence in 2 countries.

View the org chart displaying its 30 main executives

Most searched biographies at SV Health Investors

• Eugene Hill, Chairman of the Board
• Brent Faduski, Chief Financial Officer, Chief Compliance Officer a...
• Christian Jung, Partner, Biotechnology

Popular executive movements at SV Health Investors

• Nikola Trbovic, who was Partner, Biotechnology, is promoted to Managing Partner, Biotechnology  (posted on January 8 2024).
• Jamil Beg has joined the company as Partner, Biotechnology  (posted on January 8 2024).

Create your alert
to follow the executive moves at SV Health Investors.

SV Health Investors has 1,473 competitors including Lloyds Development Capital (United Kingdom (UK)), BlackRock (United States (USA)) and WindRose Health Investors (United States (USA)).

Popular M&A news in Fund

• HMC Capital has acquired StratCap (posted on February 28 2024).
• Thomvest Ventures has just announced a $250 Million fundraising (posted on January 17 2024).
• BlackRock has announced the acquisition of Global Infrastructure Partners  (posted on January 15 2024).

Popular contacts in Fund

• Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer at Valor Equity Partners
• Mortimer Buckley - Chairman of the Board and Chief Executive Officer (retiring in Dec 2024) at Vanguard
• Sebastian Barrack - Head of Commodities at Citadel

Learn more about the Fund industry >

Press releases by SV Health Investors

• SV Biotech launches its inaugural ESG and Impact Report - SV Health Investors
• Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia - SV Health Investors
• UK dementia adviser [Ruth McKernan] wants half a million volunteers for clinical trials - SV Health Investors
• Dementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia - SV Health Investors
• Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference - SV Health Investors
• Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease - SV Health Investors
• Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia - SV Health Investors
• Ribometrix to Present New Preclinical Data From RNA-Modulating Small Molecule Programs Targeting eIF4E and c-MYC at the 2024 AACR Annual Meeting - SV Health Investors
• News - SV Health Investors
• SV Venture Partner Ruth McKernan reflects on the achievemtns of - SV Health Investors
• View more press releases Close

Social media about SV Health Investors

• SV Health Investors on Wikipedia, Google News & Yahoo Finance
• SV Health Investors on LinkedIn, Twitter & YouTube

Contact by email its executives including Eugene Hill

Call SV Health Investors at +44 207...

View the org chart

Register to receive your alert

Report an error